Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Redasemtide versus placebo in adults with acute ischemic stroke
jRCT2031230083Phase 2Active, not recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jul 2023
- Modality
- Peptides
01
Overview
Phase 2, randomised, double-blind trial of redasemtide in ischemic stroke (3 arms), sponsored by Shionogi & Co., Ltd. Primary endpoint: Modified Rankin Scale score at Day 90. Started Jul 2023; status: active, not recruiting.
02
Drugs
redasemtide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on jRCT2031230083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230083.